FIELD: organic chemistry, pharmacy. SUBSTANCE: invention relates to novel derivatives of isoxazole of the general formula (I) where R1 means optionally substituted C6-C14-aryl-group or 5-6-membered heterocyclic group having one heteroatom taken among nitrogen, oxygen, sulfur; R2 means hydrogen, halogen atom, optionally substituted C1-C6-alkyl group, C2-C6-alkenyl group, C2-C6-alkynyl group, C3-C10-cycloalkyl group, C3-C10-cycloalkenyl group, cyano-group, carboxyl-group, C1-C7-alkanoyl-group, C2-C7-alkoxycarbonyl-group or optionally substituted carbamoyl-group; R3 means optionally substituted amino-group or saturated 5-6-membered heterocyclic group containing nitrogen atom; X means oxygen or sulfur atom; n means the whole number from 2 to 6, and their pharmaceutically acceptable salts. Invention relates to also pharmaceutical composition showing inhibitory activity with respect to monoaminooxidase type A and containing compound of the formula (I) or its pharmaceutically acceptable salt and pharmaceutically acceptable carrier. EFFECT: new isoxazole derivatives indicated above, valuable biochemical properties. 28 cl, 2 tbl, 107 ex
Title | Year | Author | Number |
---|---|---|---|
DERIVATIVES OF ISOXAZOLE, THEIR USE IN PRODUCTION OF AGENT INHIBITING MONOAMINE OXIDASE ACTIVITY, PHARMACEUTICAL COMPOSITION AND METHOD OF INHIBITION OF ACTIVITY OF MONOAMINE OXIDASE TYPE B | 1995 |
|
RU2140414C1 |
AMIDE DERIVATIVES, AND COMPOSITION HAVING ACAT-INHIBITING ACTIVITY | 1996 |
|
RU2128165C1 |
NOVEL TETRAHYDROISOQUINOLINE DERIVATIVE, PHARMACEUTICAL COMPOSITION BASED THEREON, USE THEREOF AND METHOD OF TREATING AND/OR PREVENTING DISEASE | 2009 |
|
RU2474575C2 |
AMIDOCARBOXYLIC ACID DERIVATIVES, PHARMACEUTICAL COMPOSITION BASED THEREON AND METHOD OF REDUCING GLUCOSE IN BLOOD | 1998 |
|
RU2176999C2 |
HETEROCYCLIC COMPOUND | 2006 |
|
RU2382781C2 |
DERIVATIVES OF PHENYLALKYLCARBOXYLIC ACID AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 1997 |
|
RU2169141C2 |
PIPERIDYLHYDROXY- OR QUINUCLIDINYLHYDROXY-ISOXAZOLE DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, COMPOSITION DECREASING COGNITIVE FUNCTION DISORDERS | 1993 |
|
RU2079496C1 |
INDANOL DERIVATIVES | 2005 |
|
RU2323937C1 |
DERIVATIVE OF CYCLIC AMINE, CONTAINING HETEROARYL CYCLE | 2004 |
|
RU2346935C2 |
SUBSTITUTED ACRYLAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION BASED ON SAID DERIVATIVE | 2006 |
|
RU2404966C2 |
Authors
Dates
2001-04-20—Published
1997-02-27—Filed